BFC Planning’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
Other funds holding ALNY
BFC Planning's ALNY Position: Q3 2026 in Review
BFC Planning increased its Alnylam Pharmaceuticals (ALNY) stake by 344% in Q3 2026, buying an estimated $114K and bringing the position to 577 shares worth $142K. The position accounts for 0.01% of the portfolio, ranked #1076.
BFC Planning first reported a position in ALNY in Q3 2024 and has held it in 9 quarters since. 604 funds tracked by Wall St. Rank hold ALNY as of Q3 2026.
- BFC Planning held 577 shares of Alnylam Pharmaceuticals worth $142K as of Q3 2026.
- BFC Planning bought 447 Alnylam Pharmaceuticals shares in Q3 2026, an estimated $114K.
- Alnylam Pharmaceuticals made up 0.01% of BFC Planning's portfolio in Q3 2026, its #1076 holding.
- BFC Planning first reported a position in Alnylam Pharmaceuticals in Q3 2024 and has held it in 9 quarters since.
- 604 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q3 2026.
Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.